Login  
Research Report
 
 
Home >> Country >> India >> Company
Company Name : Glaxo SmithKline Consumer
Y/E Mar, Rs mn FY11 FY12 FY13 FY14E FY15E
Price5208
Target4700
RecoNEU
Net Sales23,06126,85530,79435,87340,814
Growth (%)16151614
EBIDTA3,7674,2504,6534,9385,944
EBITDA Margin16151415
Net Profit2,9983,5504,3664,9905,837
Growth (%)18231417
EPS, Rs7184104119139
PER, x73.161.750.243.937.5
EV/EBIDTA, x5649444134
P/BV, x2319161412
ROE, % 3231323132
Total debt/Equity (%)-101.7-94.4-107.6-102.1-91.9
Latest Reports
Date Description Country Analyst Download
08-Nov-2019 GSK Consumer Q2FY20: Awaiting merger with HUL for next leg of growth - Maintain BUY India Vishal Gutka
05-Aug-2019 GSK Consumer Q1FY20: Awaiting merger with HUL - Maintain BUY India Vishal Gutka
13-May-2019 GSK Consumer Q4FY19: In line with estimates - Maintain BUY India Vishal Gutka
15-Feb-2019 GSK Consumer Q3FY19: Core stays strong, but adverse export mix dents performance - Maintain BUY India Vishal Gutka
02-Nov-2018 GSK Consumer Q2FY19: Faster, Higher, Stronger - Maintain BUY India Vishal Gutka
16-Oct-2018 GSK Consumer Company update : Heads, I win; tails, I don’t lose much India Vishal Gutka
09-Aug-2018 GSK Consumer Q1FY19: Re-energizing performance India Vishal Gutka
15-May-2017 GSK Consumer Q4FY17: Yearning for volume growth; Maintain BUY India Jubil Jain
14-Feb-2017 GSK Consumer Q3FY17: Yearning for volume growth; Maintain BUY India Jubil Jain
08-Nov-2016 GSK Consumer Q2FY17: Growth continues to remain subdued; Maintain BUY India Jubil Jain
05-Aug-2016 GSK Consumer Q1FY17: Sluggish quarter as expected; Maintain BUY India Jubil Jain
19-May-2016 GSK Consumer Q4FY16: Focus shifts to volume growth; Upgrade to Buy India Jubil Jain
16-Nov-2015 GSK Consumer Q2FY16 update: Sluggish volume growth concerning; Maintain Neutral India Jubil Jain
Copyright © 2013. Brought to you by PhillipCapital (India) Pvt. Ltd.      Designed and developed by C-MOTS Infotech (ISO 9001:2015 certified)